HSE National Clinical Guideline
Management of Paediatric Type 1 Diabetes Patient with a HbA1c greater than 75mmol per mol
Topic:
Paediatric type 1 diabetes hba1c > 75mmol/mol (9%)
Document Owner:
National Clinical Lead for Paediatric Diabetes
National Group:
National Clinical Programme, Paediatrics and Neonatology
Effective From: 31 March 2025
The aim of this guideline is to provide clear and standardised guidelines for all staff caring for (and advising care givers of) children and young people with very sub optimal type 1 diabetes control: HbA1c > 75mmol/mol (9%).
Optimal glycaemic control has been unequivocally shown to reduce the risk of microvascular complications in individuals with Type 1 Diabetes. Currently ISPAD recommends a target HbA1c of 53mmol/mol (7.0%) or less in those with access to comprehensive care. With the advent of newer technologies, both in the areas of continuous glucose monitoring and insulin delivery, achieving these targets is possible. However, there are still some children in whom it is difficult to achieve optimal glycaemic control.